|
The Situation
About the Book
About the Authors
Reader Responses
Audio and Other Resources
Ordering Information
| |
Support proven more
effective for schizophrenics than hospitalization and drugs
Routledge, Taylor & Francis Group
Unit 4, Park Square, Milton Park, Abingdon, Oxon, OX14 4RN, UK
MEDIA RELEASE
FOR IMMEDIATE RELEASE
23rd February 2009
PAPER IN NEW ‘PSYCHOSIS’ JOURNAL SHOWS MANY PATIENTS DO BETTER WITHOUT
PSYCHIATRIC DRUGS
The first edition of PSYCHOSIS: PSYCHOLOGICAL, SOCIAL AND INTEGRATIVE
APPROACHES was published this month. The journal, published by Routledge
in the UK, [www.tandf.co.uk/journals/psychosis] is the official
scientific journal of the International Society for the Psychological
Treatments of Schizophrenia [www.isps.org].
The very first paper, by Dr John Bola of the University of Southern
California and three European researchers, reviews the only five studies
of what happens when people diagnosed ‘schizophrenic’ are given
psycho-social support instead of anti-psychotic drugs in the first few
weeks of treatment. All five found better long-term outcomes than the
traditional approach of hospitalization and medication.
Dr Mario Maj – President, World Psychiatric Association:
“Psychosis will be extremely useful not only in providing information on
evidence-based psychotherapies and other psychosocial interventions, but
also in re-educating all of us about the importance of the psychosocial
dimension in the development, persistence and outcome of psychoses.”
Dr Paul Fink – Past President, American Psychiatric Association:
“Psychosis is going to be a monumental help to people working with
psychosis all over the world. I particularly value the fact that it
stresses psychotherapy”
Editor, Dr John Read of the University of Auckland, New Zealand:
“Psychosis fills a gap in the scientific literature, which is currently
dominated by a rather simplistic and reductionist bio-genetic model that
often seems to be based more on ideology and vested interests than on
rigorous research. This approach can lead to a minimization of
psychological and social factors and to a damaging pessimism about the
probability of recovery.”
The journal, which includes first-person accounts from people who
experience psychosis, will be one of a tiny minority of mental health
journals which will not carry drug company advertisements. Its official
international launch will be at the ISPS Congress in Copenhagen in June
[www.isps2009.ics.dk]
Editorial Contacts:
Dr John Bola
Dr John Read
j.read@auckland.ac.nz, +64-9-373-7999
- ends -
For information about the ISPS visit www.isps.org
For information about Psychosis: Psychological, Social and Integrative
Approaches visit www.tandf.co.uk/journals/psychosis
Contact:
Claire Thomas, Senior Marketing Executive
Routledge, Taylor & Francis Group
4 Park Square, Milton Park, Abingdon, Oxon, OX14 4RN, UK
Telephone: +44 (0)20 7017 6440
Fax: +44 (0) 20 7017 6713
Email:
claire.thomas@tandf.co.uk
Website: www.tandf.co.uk/journals
Ordering
Information
|
